RxDoctor Payments DataLook up a doctor →

Michael Recht

Pediatric Hematology-Oncology · New Haven, CTNPI 1366403164

Payments from drug & device makers

$1,087,433in general payments, 2019–2025

Across 354 payments — averaging $3071.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$466K
  • Spark Therapeutics, Inc.$123K
  • CSL Behring$106K
  • Novo Nordisk AS$79K
  • Genentech USA, Inc.$60K
  • Shire North American Group Inc$57K
  • plus $197K from 13 others
$29,335in research payments, 2019–2025

Across 19 payments — averaging $1543.96 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • F. Hoffmann-la Roche AG$28K
  • Bioverativ Therapeutics Inc.$618
  • Sanofi-aventis U.S. LLC$245

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

Too few pediatric hematology-oncology providers in Connecticutto place this figure against a meaningful peer group, so we don't.

Other pediatric hematology-oncology in New Haven

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →